Ex situ and in situ functionalized Yb/Fe nanoparticles obtained by scanning pulsed laser ablation in liquids: A route to obtain biofunctionalized multiplatform contrast agents for MRI and CT imaging

Abstract

Two distinct strategies were used to improve the colloidal properties of hybrid Yb/Fe oxide NPs previously prepared by the pulsed liquid laser ablation process for use as a contrast agent in medical imaging.First, an exhaustive optimization process of the laser ablation synthesis parameters was carried out to reduce the hydrodynamic diameters of the Yb/Fe NPs. The hydrodynamic size was successfully reduced to <200 nm, thereby decreasing the polydispertivity index.Second, ex situ and in situ functionalization processes using glutathione, cysteamine, or polyethylenimine as capping agents have been developed to increase their colloidal stability at physiological pH values. Transmission electron microscopy, dynamic light scattering, Z-potential measurements, and Fourier Transform Infrared spectroscopy were used to examine the structure, morphology, colloidal and surface properties of Yb/Fe NPs.Colloidal stability of the Yb/Fe NPs as well as the linkage mechanism of functionalization have been studied extensively. This last parameter provides a critical information for subsequently bioconjugations in biomedical applications. Additionally, the biocompatibility of the Yb/Fe NPs was evaluated by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) experiments. These results indicate more appropriate colloidal characteristics and higher biocompatibility for ex situ-functionalized Yb/Fe NPs, especially when the capping agent is glutathione. Additionally, these Yb/Fe NPs show good magnetic resonance imaging and X-ray computerized tomography imaging abilities, thereby indicating promising potential as dual contrast agents.